D'Angio Paul 4
4 · NexImmune, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
D'Angio Paul
Director
Transactions
- Award
Stock Option (right to buy)
2021-02-11+9,556→ 45,312 totalExercise: $17.00Exp: 2025-02-11→ Common Stock (9,556 underlying)
Footnotes (1)
- [F1]These stock options will vest and become exercisable at the first anniversary of the vesting commencement date (2/11/21).